Navigation Links
Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents
Date:2/8/2010

her important infectious agents—such as Ebola, Marburg and other hemorrhagic fever viruses—that kill hundreds of thousands of people and are of concern to the public health and bioterrorism preparedness communities.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders and vascular diseases. Corgenix sells over 50 diagnostic products through a global distribution network for use in clinical laboratories worldwide. In addition, the Company is active in the development of technology and products for emerging pathogens such as viral hemorrhagic fevers.

About Tulane University

Tulane University (New Orleans, La.) was founded in 1834. Tulane is one of the most highly regarded and selective research universities in the United States, and is a member of the prestigious Association of American Universities. Tulane's schools and colleges offer undergraduate, graduate and professional degrees in the liberal arts, science and engineering, architecture, business, law, social work, medicine and public health and tropical medicine.

About Autoimmune Technologies, LLC

Autoimmune Technologies (New Orleans, La.) is a privately held biomedical company. It has licensed several breakthrough research discoveries from Tulane University School of Medicine and has made exciting discoveries of its own. Autoimmune is working to offer new diagnostic tests and new anti-viral therapeutics to the medical community based on this proprietary research.

About Boston University

Established in 1873, '/>"/>

SOURCE Corgenix Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Corgenix Secures $1,750,000 Asset Based Credit Facility Representing Initial Gross Proceeds of $1.109 Million
2. Corgenix Reports Third Quarter Fiscal 2009 Financial Results
3. Corgenix to Exhibit AspirinWorks(R) Test at ACC.09
4. Corgenix Reports Second Quarter Fiscal 2009 Financial Results
5. Corgenix to Host Conference Call to Discuss Second Quarter Results
6. Corgenix Signs Collaboration With Battelle
7. Corgenix Receives Two Additional Patents on AtherOx(R) Technology
8. Corgenix to Host Conference Call to Discuss First Quarter Results
9. Corgenix to Exhibit AspirinWorks(R) Test, Discuss New CHARISMA Trial Results at AHA 2008 Meeting
10. Corgenix Receives Third U.S. Patent on AtherOx(R) Technology
11. Corgenix Reports Fiscal 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a primary commercial focus on China ... Type C meeting with the U.S. Food and Drug ... in February 2015.  During this meeting the Company will ...
(Date:12/15/2014)... 15, 2014 METTLER TOLEDO is ... tool, ParticleView V19 with PVM technology , ... particle vision and measurement tool continuously captures high-resolution ... ParticleView V19 then automatically prepares a report pairing ... size and concentration changes. This compelling blend of ...
(Date:12/15/2014)... NEW YORK , Dec. 15, 2014  GlassesOff ... Yuval Bar-Gil as an independent director of ... was founder of AeroScout and served as its CEO ... Decker in 2012, a $240 million transaction. Recognized as ... under Mr. Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID ...
(Date:12/13/2014)... 13, 2014 CanDiag, Inc., a University ... has changed its name to OncoTab, Inc. , ... where we are today,” said CEO and Chief Science ... applications beyond breast cancer diagnostics to include imaging and ... that evolution.” , Founded in 2011 by Dr. Mukherjee, ...
Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2
... , ... that the European Investment Fund (EIF) has entered into ... be,managed by Karolinska Development and used to invest in ... EIF,has agreed to invest 26.7 M Euros in the ...
... ... a free webinar, “The Role of Process Analytical Technology (PAT) in Green Chemistry and ... ... of Process Analytical Technology (PAT) in Green Chemistry and Green Engineering Webinar on ...
... SEATTLE, Nov. 19 Omeros Corporation (Nasdaq: OMER ) today ... 2009. For the three months ended September 30, 2009, Omeros reported ... compared to a net loss of $7.4 million, or $2.54 per ... ended September 30, 2009, the Company reported a net loss of ...
Cached Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/4/2014)... PALM BEACH GARDENS, Fla. , Dec. 3, ... identity management solutions, today announced that its DigitalPersona ... 4500 fingerprint readers have been deployed throughout ... Carolina , South Carolina ... network headquartered in Southern Pines, North ...
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... This news release is available in German . ... is made up of a highly concentrated protein solution that imparts ... content the ocular lens must remain clear and transparent. To this ... thrown overboard the complex machinery present in all other cells of ...
... study led by scientists at the University of Miami (UM) ... complex circulation from the Mississippi River plume played a substantial ... the 2010 Deepwater Horizon incident. These findings provide new information ... Gulf of Mexico. The research, published in the Oct. 2013 ...
... use in vaccines and cancer medicines, enzymes for the ... already be produced on a large scale using biotechnology. ... making use of living cells or organisms. This involves ... protein to bacteria, yeasts, or cultures of animal or ...
Cached Biology News:A protein safeguards against cataracts 2A protein safeguards against cataracts 3New research illustrates Mississippi River's role 2Biomolecules for the production line 2Biomolecules for the production line 3
...
... is specifically designed for two-dimensional electrophoresis ... four proteins in this marker have ... pattern across a 2D gel. The ... Mol wt: 17,000-89,000 ...
... HEXALIGHT robot is based on PI's experience ... more than a decade. PI Hexapods were ... and antenna adjustments over wide ranges in ... degrees of freedom with 3 m minimum ...
... full length insert sequencing service for large ... fosmids. Agencourt utilizes unique library construction ... There are several features that allow Agencourt ... rapid turnaround including our patented magnetic bead-based ...
Biology Products: